Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -6.83%5.72M | 9.17M | 19.06%23.28M | 13.50%5.42M | 2.59%3.17M | 54.82%19.55M | 6.14M | 60.48%5.56M | 84.49%4.77M | 3.09M |
| Cost of revenue | 13.21%6.05M | 7.34M | 19.52%17.75M | 20.09%4.14M | 32.25%2.45M | 28.76%14.85M | 5.34M | 22.58%4.21M | 75.93%3.45M | 1.85M |
| Gross profit | -141.69%-331K | 1.83M | 17.60%5.53M | -3.71%1.27M | -41.90%717K | 329.53%4.7M | 794K | 4,258.06%1.35M | 111.36%1.32M | 1.23M |
| Operating expense | 0.89%11.79M | 1.44M | -70.24%4.26M | 8.40%1.11M | 2.37%949K | -49.05%14.33M | 11.69M | -81.82%937K | -49.88%1.02M | 927K |
| Selling and administrative expenses | -15.49%1.41M | --1.27M | -0.68%4.52M | 2.54%1.05M | 2.82%947K | -19.92%4.55M | --1.67M | 15.82%937K | 6.90%1.02M | --921K |
| -Selling and marketing expense | -14.29%6K | --16K | 40.00%49K | 80.00%18K | 100.00%12K | -5.75%35K | --7K | 50.00%12K | 0.00%10K | --6K |
| -General and administrative expense | -15.50%1.41M | --1.25M | -1.00%4.47M | 1.78%1.03M | 2.19%935K | -20.01%4.52M | --1.67M | 15.48%925K | 6.97%1.01M | --915K |
| Other operating expenses | 2.80%10.38M | --172K | -99.48%53K | 6,000.00%61K | -66.67%2K | -54.95%10.11M | --10.1M | ---- | -99.91%1K | --6K |
| Total other operating income | ---- | ---- | -6.02%312K | ---- | ---- | --332K | --80K | ---- | ---- | ---- |
| Operating profit | -11.28%-12.13M | 388K | 113.13%1.26M | -45.45%162K | -175.57%-232K | 64.38%-9.63M | -10.9M | 108.08%414K | 120.94%297K | 307K |
| Net non-operating interest income (expenses) | -46.74%-135K | -146K | -29.04%-471K | -32.94%-113K | 7.95%-81K | 22.43%-365K | -92K | -11.11%-100K | 16.67%-85K | -88K |
| Non-operating interest expense | 46.74%135K | --146K | 29.04%471K | 32.94%113K | -7.95%81K | -22.43%365K | --92K | 11.11%100K | -16.67%85K | --88K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 132.68%185K | 43K | -37.01%80K | -21.28%74K | -7.87%331.51K | 79.51K | -62.20%31K | 78.87%127K | 94K | |
| Income before tax | -9.89%-12.08M | 285K | 107.94%793K | -61.95%129K | -176.36%-239K | 63.18%-9.99M | -10.99M | 106.72%345K | 123.40%339K | 313K |
| Income tax | 340.00%110K | 0 | -75.63%48K | 0 | -30.56%50K | 13.39%197K | 25K | 1,500.00%32K | 21.43%68K | 72K |
| Net income | -10.64%-12.19M | 285K | 107.31%745K | -52.40%129K | -219.92%-289K | 62.69%-10.19M | -11.01M | 106.10%313K | 118.01%271K | 241K |
| Net income continuous operations | -10.64%-12.19M | --285K | 107.31%745K | -52.40%129K | -219.92%-289K | 62.69%-10.19M | ---11.01M | 106.10%313K | 118.01%271K | --241K |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | -10.64%-12.19M | 285K | 107.31%745K | -52.40%129K | -219.92%-289K | 62.69%-10.19M | -11.01M | 106.10%313K | 118.01%271K | 241K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -10.64%-12.19M | 285K | 107.31%745K | -52.40%129K | -219.92%-289K | 62.69%-10.19M | -11.01M | 106.10%313K | 118.01%271K | 241K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.11%-0.0473 | 0.0011 | 106.97%0.0029 | -58.33%0.0005 | -200.00%-0.0012 | 70.52%-0.0416 | -0.045 | 104.53%0.0013 | 113.64%0.0012 | 0.0012 |
| Diluted earnings per share | -5.11%-0.0473 | 0.0011 | 106.97%0.0029 | -54.55%0.0005 | -220.00%-0.0012 | 70.52%-0.0416 | -0.045 | 104.18%0.0012 | 112.50%0.0011 | 0.001 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.